سمپوزیوم منطقه ای نوآوری در علم و فناوری

English

صفحه اصلی / دومین سمپوزیوم منطقه ای نوآوری در علم و فناوری

Combining Machine Learning and Nanobiosensors for Improving Lung Cancer Detection

نویسندگان :

Shakiba Nazemian¹ Soheil Sadr² Ashkan Hajjafari³ Khashayar Hajjafari⁴ Abbas Rahdar⁵ Mahdis Khajehmohammadi⁶ Hassan Borji⁷

1- Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mas 2- Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran 3- Department of Pathobiology, Faculty of Veterinary Specialized Science, Science, and Research Branch, Islamic Azad University, Tehran, Iran 4- Medical Doctor, Shahid Bahonar University of Kerman, Kerman, Iran 5- Department of Physics, University of Zabol, Zabol, Iran 6- Department of Basic Sciences, Faculty of Veterinary Medicine, Baft branch, Islamic Azad University, Baft, Iran 7- Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran

کلمات کلیدی :

Lung cancer،Nanotechnology،Nanobiosensors،Artificial intelligence

چکیده :

Abstract- Lung cancer is one of the most prevalent types of cancer in the world, and its clinical prognosis and early detection are of great importance. With recent advances in artificial intelligence and nanotechnology, combining machine learning (ML) and nanobiosensors has been considered a novel approach for diagnosing and monitoring lung cancer. Hence, the current review aims to examine the combination of these two technologies for lung cancer diagnosis and explores its potential and challenges. ML can identify patterns associated with lung cancer with its capabilities in processing complex data and simulating predictive models. Nanobiosensors, on the other hand, can detect biological changes at the molecular and cellular levels with high sensitivity. These two technologies allow for more accurate, faster, and non-invasive lung cancer diagnosis. In addition, using these two technologies simultaneously could help identify more advanced changes in the disease, even before clinical symptoms become apparent. In conclusion, combining machine learning and nanobiosensors offers a novel and efficient approach to lung cancer diagnosis that can significantly increase the accuracy of diagnosis and prognosis.